Cysteine Supplementation in Critically Ill Neonates

Clinical trial NCT00254176 · UNKNOWN

Trial details

NCT number: NCT00254176
Sponsor: University of California, Los Angeles
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sepsis Bronchopulmonary Dysplasia Necrotizing Enterocolitis Retinopathy of Prematurity Systemic Inflammatory Response Syndrome

Start date: 2006-09-01
Primary completion: 2011-03-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.